Top View
- The Tyrosine Kinase Lck Is Involved in Regulation of Mitochondrial Apoptosis Pathways
- LCK, Active Full-Length Human Recombinant Protein Expressed in Sf9 Cells
- Negative Regulation of Lck by Cbl Ubiquitin Ligase
- Tech Note U-TRF # 15 JAK3 Kinase Assay
- Proximal Lck Promoter–Driven Cre Function Is Limited in Neonatal and Ineffective in Adult Gd T Cell Development
- Phosphoproteomic Mass Spectrometry Profiling Links Src Family Kinases to Escape from HER2 Tyrosine Kinase Inhibition
- Tyrosine Kinase Inhibition Increases the Cell Surface Localization of FLT3-ITD and Enhances FLT3-Directed Immunotherapy of Acute Myeloid Leukemia
- The Role of Janus Kinase 3 in CD4+ T Cell Homeostasis and Function: a Dissertation
- Regulation of PDGFR Signaling
- High Throughput Kinase Discovery, Inhibitor Screening and Specificity Analysis Using Multi-Array Technology
- Class Effects of Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia
- FLT3 Signalling Pathways in Acute Myeloid Leukaemia
- Immune Cell Guide
- Intensity and Duration of TCR Signaling Is Limited by P38 Phosphorylation of ZAP-70T293 and Destabilization of the Signalosome
- Smarcc1 Crebbp Smarcc1 Ar Smarcc1 Gata1 Smarcc1
- Cooperative Interaction of Nck and Lck Orchestrates Optimal TCR Signaling
- Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab Treatment
- The Proto-Oncogene C-Kit Inhibits Tumor Growth by Behaving As a Dependence Receptor Hong Wang
- Pharmacogenomics in Pediatric Oncology: Review of Gene–Drug Associations for Clinical Use
- Evidence for Activated Lck Protein Tyrosine Kinase As the Driver Of
- Of Lck Directs the Spatial Distribution and Activity the Late Endosomal Transporter CD222
- Online Supplementary Data for Molecular and Phenotypic Features
- Early Tumor Response to Hsp90 Therapy Using HER2 PET: Comparison with 18F-FDG PET
- LCK LCK Kinase Assay
- The Tyrosine Kinase Lck Is a Positive Regulator of the Mitochondrial Apoptosis Pathway by Controlling Bak Expression
- Characterising the Role of Zeb1 in the Adult Haematopoietic System Alhomidi Almotiri
- Regulation of Src Family Kinases During Colorectal Cancer Development and Its Clinical Implications
- Modulation of the C-Met/Hepatocyte Growth Factor Pathway in Small Cell Lung Cancer1
- Network Pharmacology of JAK Inhibitors
- A Constitutively Active Lck Kinase Promotes Cell Proliferation and Resistance to Apoptosis Through Signal Transducer and Activator of Transcription 5B Activation
- Inkascore.Org Phosphoproteomics Data Analysis Version 0.2.1 Running
- Src Family Kinases and HER2 Interactions in Human Breast Cancer Cell Growth and Survival
- Cluster of Differentiation Antigen 135; CD135; Fms Like Tyrosine Kinase 3
- C-Src Recruitment Is Involved in C-MET-Mediated Malignant Behaviour of NT2D1 Non-Seminoma Cells
- Anaplastic Lymphoma Kinase: Role in Specific Tumours, and Development of Small Molecule Inhibitors for Cancer Therapy ⇑ E
- Dasatinib and Navitoclax Act Synergistically to Target NUP98-NSD1 +/FLT3-ITD+ Acute Myeloid Leukemia
- LCK, Active Full-Length Human Recombinant Protein Expressed in Sf9 Cells
- Antigen Receptor Lck Function Downstream of the T Cell Focal Adhesion Kinase Negatively Regulates
- Sample Report. for Illustrative Purposes Only. Not for Clinical Use
- Substrate Recognition by the Lyn Protein-Tyrosine Kinase
- Lymphocyte Cell Kinase Activation Mediates Neuroprotection During Ischemic Preconditioning
- Ctk: a Protein-Tyrosine Kinase Related to Csk That Defines an Enzyme Family SABINE KLAGES*, DIETER ADAM*, KENNETH CLASS, JOSEPH FARGNOLI, JOSEPH B
- Combining Molecular Imaging with Targeted Cancer Therapy
- A Novel, LAT/Lck Double Deficient T Cell Subline J.Cam1.7 For
- Structural Analysis of the Lymphocyte-Specific Kinase Lck in Complex with Non-Selective and Src Family Selective Kinase Inhibito
- Delineating the Biology of Anaplastic Lymphoma Kinase (ALK)
- Source Target LCK ZAP70 EGFR ERBB2 RIPK1 RIPK3 RPS6KA3 MAPK1 SRC EGFR SRC PTK2 SYK LCK SRC ERBB2 SRC PTK2B SRC KDR FYN PRKCD
- T Cell Activation of Contribution of Lck to Negative Regulation Superantigen Stimulation Reveals
- The Src Family Kinase LCK Cooperates with Oncogenic FLT3/ ITD in Cellular Transformation Received: 31 May 2017 Alissa Marhäll1,2, Julhash U
- Oclacitinib (APOQUEL) Is a Novel Janus Kinase Inhibitor with Activity
- Identification of Shc Docking Site on Ret Tyrosine Kinase
- Mechanism of Activation for Zap-70 Catalytic Activity PHILIP V
- CD2 Promoter Regulated Nucleophosmin-Anaplastic Lymphoma Kinase in Transgenic Mice Causes B Lymphoid Malignancy
- Crystal Structure of the Activated Insulin Receptor Tyrosine Kinase in Complex with Peptide Substrate and ATP Analog
- The Activation Loop in Lck Regulates Oncogenic Potential by Inhibiting Basal Kinase Activity and Restricting Substrate Speci®City
- The Kinase Inhibitor PP1 Blocks Tumorigenesis Induced by RET Oncogenes1
- PTK2 Protein Tyrosine Kinase 2; PTK2; Focal Adhesion Kinase